|
English
|
正體中文
|
简体中文
|
总笔数 :2851816
|
|
造访人次 :
44936591
在线人数 :
1170
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"srimuninnimit v"的相关文件
显示项目 11-14 / 14 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
|
Chia-Chi Lin; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K.; Srimuninnimit V; Ahn M.-J; Mok T; Kang J.H; Yang J.C.-H |
| 臺大學術典藏 |
2020-05-25T07:35:18Z |
Gefitinib maintenance therapy versus gefitinib monotherapy in east asian never-smoker patients with locally advanced or metastatic nonsquamous non-small cell lung cancer: Final overall survival results from a randomized phase 3 study
|
Wang X; Park K.; Yang J.C.-H; Srimuninnimit V; Ahn M.-J; Chia-Chi Lin; Kim S.-W; Tsai C.-M; Mok T; Orlando M; Puri T |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
Benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patients
|
Dewi S;Larsen S;Srimuninnimit V;Yen-Shen Lu;Manuaba T;Lindk?R-Jensen S.; Dewi S; Larsen S; Srimuninnimit V; YEN-SHEN LU; Manuaba T; Lindk?r-Jensen S. |
| 國立臺灣大學 |
2012 |
BIOMARKER ANALYSES AND OVERALL SURVIVAL (OS) FROM THE RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3, FASTACT-2 STUDY OF INTERCALATED ERLOTINIB WITH FIRST-LINE CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
|
Mok, T. S. K.; Lee, J. S.; Zhang, L.; Yu, C.; Thongprasert, S.; Ladrera, G. E. I.; Srimuninnimit, V.; Truman, M. I.; Klughammer, B.; Wu, Y. |
显示项目 11-14 / 14 (共1页)
1
每页显示[10|25|50]项目
|
